nonsensemedi
messeng
rna
mrna
decay
nmd
surveil
pathway
use
cell
control
qualiti
mrna
finetun
transcript
abund
nmd
play
import
role
cell
cycl
regul
cell
viabil
dna
damag
respons
also
serv
barrier
viru
infect
disturb
control
mechan
caus
genet
mutat
dysregul
nmd
pathway
lead
patholog
includ
neurolog
disord
immun
diseas
cancer
role
nmd
cancer
develop
complex
act
promot
barrier
tumour
progress
cancer
cell
exploit
nmd
downregul
key
tumour
suppressor
gene
tumour
adjust
nmd
activ
adapt
aggress
immun
microenviron
latter
case
might
provid
avenu
therapeut
intervent
nmd
inhibit
shown
lead
product
neoantigen
stimul
immun
system
attack
tumour
reason
understand
biolog
cooption
pathway
nmd
import
develop
novel
therapeut
agent
inhibitor
whose
design
make
use
mani
structur
avail
nmd
studi
play
crucial
role
character
provid
divers
therapeut
option
pathway
cancer
diseas
precis
regul
genet
inform
pass
gene
transcript
protein
crucial
surviv
cell
organ
singl
gene
multipl
matur
messeng
rna
mrna
transcript
aris
altern
premrna
result
matur
speci
differ
code
noncod
region
even
beyond
endpoint
mrna
transcript
qualiti
quantiti
mrna
cell
tightli
control
variou
pathway
nonsensemedi
mrna
decay
nmd
critic
cellular
surveil
mechan
recogn
elimin
aberr
rna
contain
prematur
termin
codon
ptc
abnorm
long
untransl
region
utr
nmd
first
found
affect
onethird
mutat
mrna
transcript
destabil
ptc
code
region
product
endogen
gene
nonsens
frameshift
mutat
pseudogen
altern
splice
event
lead
intron
retent
inclus
ptccontain
exon
avoid
produc
ctermin
truncat
protein
deleteri
effect
organ
transcript
harbour
ptc
recogn
subsequ
degrad
mammalian
cell
discrimin
ptccontain
transcript
depend
posit
ptc
mrna
transcript
contain
ptc
least
nucleotid
upstream
last
exonexon
cell
lysat
preferenti
bind
hypophosphoryl
propos
involv
activ
phosphoryl
mediat
chang
interact
pattern
within
nmd
propag
nmd
activ
termin
prolinerich
region
heat
huntingtin
elong
factor
protein
phosphatas
yeast
kinas
domain
fat
focal
adhes
kinas
domain
frb
pikk
phosphatidylinositol
protein
kinas
domain
fatc
ctermin
fat
domain
gfoldlik
domain
involv
dimer
mani
pathway
lead
degrad
nmdtarget
rna
studi
show
yeast
ptccontain
transcript
degrad
predominantli
deadenylationindepend
process
involv
decap
enzym
exonucleot
digest
human
cell
transcript
degrad
multipl
mechan
endonucleolyt
cleavag
exosom
mediat
decay
deadenylationdepend
decap
lykkeandersen
et
al
perform
transcriptomewid
identif
nmd
substrat
decay
intermedi
establish
endonucleolysi
wide
initi
degrad
human
nonsens
rna
wherea
decap
use
lesser
extent
protein
conserv
cysteinehistidinerich
domain
chdomain
follow
two
recalik
domain
helicas
region
sq
serineglutamin
domain
figur
structur
analysi
known
bind
protein
chdomain
activ
atpas
helicas
activ
figur
structur
consist
four
core
region
three
domain
middl
portion
eukaryot
initi
factor
domain
ctermin
domain
ctermin
domain
protein
play
import
function
role
bind
chdomain
enhanc
helicas
activ
particularli
domain
interact
rrm
rna
recognit
motif
domain
protein
figur
well
protein
interact
domain
time
noncompetit
way
protein
show
direct
bind
rna
despit
rnp
domain
ribonucleoprotein
rrm
nterminu
figur
protein
phosphoryl
phosphoinositid
relat
kinas
associ
two
cofactor
eukaryot
releas
factor
result
phosphoryl
recruit
protein
recruit
compon
share
phosphoserinebind
domain
function
depend
phosphoryl
dephosphoryl
cycl
atpas
helicas
activ
protein
interest
area
need
investig
interact
result
stabl
heterodim
complex
compos
two
ejcbind
motif
ebm
protein
harbour
endonucleas
activ
cleav
ptcmrna
figur
identifi
structur
function
relationship
interact
protein
would
interest
area
investig
despit
increas
understand
nmd
process
question
remain
around
rule
govern
nmd
target
select
vari
organ
cell
type
transcript
subject
nmd
target
extend
beyond
classic
understand
machineri
beyond
mrna
ptc
code
region
number
featur
target
differ
rnaspeci
degrad
nmd
addit
target
classifi
three
main
categori
transcript
destabil
ptc
aris
pseudogen
altern
splice
event
lead
intron
retent
inclus
ptccontain
exon
transcript
limit
clear
code
potenti
small
rna
deriv
intragen
region
long
noncod
rna
mrna
inactiv
transposon
transcript
upstream
open
read
frame
abnorm
long
utr
wildtyp
mrna
atyp
featur
demonstr
nmd
process
occur
even
without
presenc
ejc
bound
mrna
pathway
bind
utr
transcript
interact
exonexon
junction
compon
found
cytoplasm
ejc
stabli
associ
utr
mechan
process
still
fulli
understood
lykkeandersen
et
al
perform
transcriptomewid
identif
nmd
substrat
cell
line
found
gene
host
small
nucleolar
rna
snorna
microrna
mirna
significantli
enrich
among
nmd
substrat
research
hypothes
snorna
host
gene
need
highli
transcrib
regul
high
demand
snorna
product
express
individu
snorna
cognat
splice
rna
uncoupl
altern
splice
nmd
studi
long
noncod
rna
indic
mani
contain
long
region
locat
downstream
stop
codon
unprotect
ribosom
consid
long
utr
trigger
nmd
translat
termin
upstream
ribosomefre
region
give
mechanist
explan
recognit
elimin
noncod
rna
nmd
pathway
nmd
play
role
natur
mainten
regul
abund
larg
number
cellular
rna
pathway
unmut
mammalian
mrna
act
regul
cellular
adapt
environment
chang
differenti
cell
surviv
exampl
nmd
play
known
role
homeostasi
cell
embryon
develop
cellular
respons
stress
regul
immun
respons
consequ
nmd
respons
must
strict
control
order
avoid
undesir
alter
gene
express
program
cell
tissu
evolut
organ
becom
depend
nmd
pathway
mainten
homeostasi
normal
cellular
transcript
case
nematod
yeast
mutat
main
nmd
compon
lead
discret
phenotyp
howev
human
rnaibas
knockdown
nmd
gene
show
pathway
play
crucial
role
cell
cycl
regul
cell
viabil
respons
amino
acid
starvat
furthermor
nmd
compon
nmdindepend
function
dna
damag
respons
mainten
telomer
integr
regul
calcium
metabol
viral
infect
replic
tumourigenesi
nmd
also
affect
transcript
encod
splice
regul
serinearginin
sr
protein
sr
protein
interact
exon
enhanc
stimul
exon
inclus
factor
shown
autoregul
express
creat
negativefeedback
loop
exampl
abnorm
high
express
induc
altern
splice
mrna
isoform
harbour
prematur
termin
codon
get
degrad
nmd
nonsensemedi
mrna
decay
act
biolog
switch
remov
altern
splice
mrna
protein
product
need
consid
onethird
splice
variant
produc
human
gene
harbour
ptc
nmd
process
also
function
regul
altern
splice
transcriptom
role
nmd
pathway
embryogenesi
neuron
develop
recent
review
lou
et
al
studi
human
embryon
stem
cell
line
esc
found
nmd
factor
highli
express
pluripot
stem
cell
show
nmd
aid
pluripot
human
esc
mammalian
cell
disrupt
result
embryon
lethal
mice
addit
proven
crucial
embryogenesi
influenc
regul
target
gene
via
altern
splice
coupl
nmd
studi
demonstr
vital
function
earli
mous
develop
link
loss
nmd
compon
widespread
chang
mammalian
transcriptom
discov
disrupt
nmd
compon
develop
result
male
infertil
downregul
gene
earli
stage
spermatogenesi
lead
loss
nmd
disappear
vast
major
spermatogen
cell
interestingli
get
disrupt
postmeiot
stage
decreas
nmd
activ
long
utr
ejcassoci
nmd
disrupt
nmd
pathway
take
part
mani
crucial
physiolog
process
respons
stress
regul
immun
system
viral
replic
context
stress
nmd
incorpor
among
sever
strategi
design
counter
stress
restor
homeostasi
altern
divert
cellfat
toward
apoptosi
stress
mitig
involv
repress
nmd
seen
stress
includ
nutrient
depriv
hypoxia
infect
inhibit
nmd
partial
mediat
phosphoryl
translat
initi
factor
stop
translat
process
common
step
sever
stress
respons
scheme
downregul
nmd
pathway
activ
allow
accumul
nmdtarget
transcript
includ
stressresponsefactor
increas
cell
surviv
nmd
also
act
regul
unfold
protein
respons
upr
activ
endoplasm
reticulum
er
stress
erstress
imbal
protein
fold
demand
fold
capac
er
result
increas
amount
unfold
protein
physiolog
benefici
pathway
upr
requir
tight
regul
avoid
deleteri
consequ
persist
activ
upr
caus
wide
varieti
human
diseas
therefor
unfold
protein
respons
pathway
must
undergo
strict
regul
physiolog
state
nmd
protect
cell
overactiv
upr
stress
condit
nmd
inhibit
trigger
upr
respons
upregul
upr
sensor
howev
consequ
inhibit
accumul
truncat
misfold
protein
er
lead
cellular
stress
signal
nmd
reactiv
help
end
stress
respons
lead
homeostasi
nmd
pathway
also
play
import
role
regul
immun
system
signal
molecul
cytokin
modul
inflamm
respons
infect
upregul
bind
cytokin
receptor
cell
surfac
initi
immun
respons
cascad
observ
along
rnabind
protein
degrad
cytokin
mrna
first
stage
inflamm
respons
bind
mrna
act
downregul
transcript
hand
rnabind
protein
roquin
function
manner
regul
late
phase
inflamm
shown
nmd
pathway
control
stabil
transcript
encod
cytokin
receptor
thu
influenc
inflamm
respons
mrna
human
cytokin
receptor
harbor
program
ribosom
frameshift
signal
direct
translat
ribosom
ptc
lead
mrna
downregul
along
role
immun
respons
regul
nmd
also
serv
natur
barrier
viru
replic
research
conduct
balistreri
et
al
show
downregul
increas
level
viral
protein
lead
higher
viral
infect
conclud
nmd
function
import
antivir
respons
provid
first
line
cell
defenc
viru
sens
induct
effector
virus
also
evolv
mechan
escap
nmdmediat
degrad
one
way
escap
decay
pathway
integr
stabil
element
utr
may
prevent
function
hand
human
tcell
lymphotrop
viru
type
viru
use
tax
rex
protein
inhibit
nmd
interact
tax
induc
accumul
phosphoryl
pbodi
lead
enhanc
stabil
mrna
waga
et
al
demonstr
mrna
coronavirus
cov
show
multipl
featur
subject
nmd
pathway
multipl
openread
frame
orf
intern
stop
codon
make
long
utr
led
conclus
cov
evolv
strategi
inhibit
nmd
pathway
studi
identifi
nucleocapsid
protein
inhibit
nmd
protect
viral
rna
decay
lead
effici
replic
coronaviru
process
nmd
inhibit
shown
promot
accumul
viral
transcript
earli
stage
infect
consid
role
nmd
play
regul
stress
immun
respons
inhibit
host
nmd
activ
nucleocapsid
protein
contribut
pathogen
cov
mechan
nmd
restrict
viral
replic
destabil
viral
transcript
contain
intern
stop
codon
long
utr
also
observ
plant
similarli
plant
virus
also
evolv
way
escap
nmd
modifi
host
endogen
nmd
activ
prove
host
nmd
respons
reduc
viral
infect
evolutionari
conserv
process
well
modul
nmd
pathway
counteract
virus
broad
bioinformat
analysi
rnaseq
data
human
cell
line
knockdown
key
nmd
compon
demonstr
endoneucleolyt
exonucleolyt
smg
mediat
decay
rout
redund
degrad
mrna
intron
utr
region
observ
nmd
target
upstream
open
read
frame
uorf
long
utr
tend
categor
transcript
factor
stress
respons
gene
oncogen
better
understand
nmd
regul
immun
respons
might
lead
new
therapeut
strategi
fight
immunerel
diseas
includ
autoimmun
immuneevas
cancer
exampl
upregul
nmd
pathway
help
bring
back
immun
homeostasi
chronic
inflamm
megabas
constitut
human
exon
sequenc
singl
nucleotid
mutat
could
gener
transcript
ptc
surpris
sever
germlinevari
popul
implic
diseas
includ
cystic
fibrosi
duchenn
muscular
dystrophi
human
genet
diseas
nmd
play
two
role
degrad
ptc
contain
transcript
benefici
context
feedback
loop
increas
depend
healthi
transcript
nmd
limit
effect
domin
neg
mutat
howev
ptc
would
result
partial
function
truncat
protein
destruct
transcript
nmd
could
increas
sever
diseas
diseas
caus
defect
gene
often
due
nonsens
mutat
gene
heterozygot
ptc
first
second
exon
often
asymptomat
owe
nmd
downregul
mutat
gene
red
blood
cell
nmd
buffer
mutat
suffici
amount
favour
normal
allel
hand
ptc
final
exon
seem
escap
nmd
pathway
lead
high
level
truncat
transcript
protein
surveil
system
red
blood
cell
fail
remov
truncat
caus
clinic
phenotyp
heterozygot
call
thalassemia
intermedia
mammalian
cell
express
chang
brain
develop
mutat
impair
nmd
function
inhibit
proper
neurit
outgrowth
observ
patient
carri
mutat
display
facial
dysmorph
neurolog
abnorm
includ
schizophrenia
autism
interestingli
degre
mental
retard
among
patient
depend
amount
protein
produc
respons
defici
anoth
exampl
overexpress
doubl
homeobox
transcript
factor
observ
muscular
dystrophi
facioscapulohumer
muscular
dystrophi
fshd
lead
activ
proteolyt
degrad
therefor
nmd
inhibit
mrna
also
nmd
target
mean
doubleneg
feedback
loop
inhibit
nmd
protein
result
stabl
transcript
fshd
muscl
cell
stopcodon
readthrough
main
therapeut
approach
pursu
treat
nmdimplic
diseas
strategi
depend
smallmolecul
readthrough
agent
induc
translat
machineri
ignor
ptc
instead
recod
amino
acid
result
fulllength
protein
potenti
function
amelior
diseas
aminoglycosid
use
caus
readthrough
termin
codon
misincorpor
amino
acid
correspond
nearcogn
transfer
rna
trna
gentamicin
anoth
readthrough
agent
util
clinic
trial
cystic
fibrosi
duchenn
muscular
dystrophi
trial
show
efficaci
readthrough
agent
restor
protein
function
unfortun
high
dose
gentamicin
requir
achiev
clinic
util
treatment
may
advers
effect
ataluren
pitch
altern
report
select
promot
ptc
readthrough
normal
stop
codon
howev
molecular
mechan
action
challeng
futur
use
clinic
larg
depend
patient
outcom
current
ongo
clinic
trial
grow
evid
magnitud
nmd
compon
often
inhibit
cancer
cell
role
nmd
pathway
tumour
complex
nmd
protect
diseas
aggrav
diseas
phenotyp
depend
natur
mutat
trigger
nmd
type
diseas
dual
function
nmd
document
mani
studi
focus
nmd
effect
human
inherit
genet
diseas
tumour
exploit
nmd
downregul
tumoursuppressor
express
select
mutat
caus
destruct
transcript
hand
cancer
cell
adjust
nmd
activ
adapt
tumour
microenviron
understand
certain
tumour
use
nmd
pathway
benefit
may
help
develop
new
therapeut
intervent
cancer
nmd
act
buffer
hide
aberr
mutat
carri
forward
diseas
progress
benefici
exampl
transcript
encod
tumour
promot
domin
neg
truncat
form
tumoursuppressor
protein
degrad
ptccarri
transcript
nmd
pathway
protect
heterozyg
germlin
carrier
cancer
mutant
develop
cancer
phenomenon
well
document
domin
neg
heterozyg
mutant
tumour
suppressor
gene
germlin
mutat
gene
lead
famili
case
ovarian
breast
cancer
express
truncat
shown
caus
chemoresist
decreas
suscept
apoptosi
decreas
vivo
tumour
growth
suppress
well
inhibit
protect
estrogen
receptor
transcript
activ
suggest
truncat
protein
function
inhibit
activ
wildtyp
contrast
target
degrad
fullyor
partiallyfunct
tumour
suppressor
protein
nmd
pathway
potenti
increas
sever
cancer
exampl
adhes
protein
ecadherin
retain
partial
function
truncat
cterminu
case
hereditari
diffus
gastric
cancer
hdgc
germlin
mutat
ecadherin
gene
often
lead
ptc
gener
activ
nmd
reduc
level
protect
protein
bia
observ
patient
harbour
mutat
extrem
end
gene
abl
escap
nmd
patient
reduc
risk
develop
hdgc
compar
peopl
harbour
nmdactiv
mutat
aberr
directli
affect
nmd
machineri
abund
nmd
compon
also
occur
cancer
indic
disrupt
normal
nmd
function
sometim
toler
promot
diseas
exampl
somat
mutat
gene
pancreat
adenosquam
carcinoma
asc
tumour
describ
somat
point
mutat
cluster
two
region
gene
mani
seem
trigger
altern
splice
premrna
lead
express
truncat
protein
similarli
express
shown
lower
lung
adenocarcinoma
adc
compar
normal
tissu
characterist
lead
decreas
nmd
activ
lead
upregul
gene
typic
nmd
control
exampl
transform
growth
factor
beta
signal
compon
vital
epithelialtomesenchym
transit
emt
emt
epitheli
cell
lose
cell
polar
cellcel
adhes
discov
express
neg
correl
hpv
human
papillomaviru
statu
cancer
cell
line
tumour
hpv
link
subset
head
neck
squamou
cell
carcinoma
hnscc
patient
hpvposit
tumour
show
better
prognosi
hpvneg
hnscc
may
explain
increas
sensit
hpvposit
hnscc
ioniz
radiat
ir
gubanova
et
al
show
low
level
result
elev
sensit
ioniz
radiat
due
increas
induct
apoptosi
hpvposit
hnscc
deplet
hpvneg
hnscc
cell
result
increas
radiat
sensit
overexpress
protect
hpvposit
tumour
cell
irradi
tumour
evolut
also
impact
nmd
buffer
lethal
passeng
mutat
aris
tumour
explor
sequenc
space
tumour
progress
may
becom
addict
nmd
pathway
capac
conceal
deleteri
event
sequenc
space
explor
tumoursuppressor
gene
exhibit
high
number
nonsens
mutat
trigger
nmd
therefor
lower
level
benefici
tumour
suppressor
protein
contrast
oncogen
harbour
missens
mutat
elicit
nmd
case
nmdescap
allow
elev
oncoprotein
express
nmd
modul
observ
tumour
microenviron
influenc
fate
tumour
wang
et
al
mrna
significantli
upregul
osteosarcoma
cell
respons
nmd
inhibit
scientist
test
rnamedi
deplet
expos
cell
hypoxia
incub
er
stress
induc
tunicamycin
data
show
among
upregul
transcript
protein
involv
tumourpromot
pathway
overrepres
mani
nmd
substrat
shown
upregul
vivo
tumour
model
well
burkitt
lymphoma
melanoma
breast
prostat
cancer
prostat
cancer
cell
overexpress
shown
make
cell
longer
sensit
nmd
inhibit
cellular
stress
grow
threedimension
sphere
xenograft
nude
mice
howev
growth
standard
tissu
cultur
condit
unaffect
studi
suggest
nmd
inhibit
tumour
microenviron
import
mechan
gene
regul
crucial
tumourigenesi
dictat
outcom
malign
develop
inhibitor
variou
compon
nmd
pathway
critic
gain
mechanist
insight
nmd
function
provid
new
avenu
therapeut
intervent
lindeboom
et
al
analys
pancanc
cohort
found
burden
frameshift
mutat
trigger
nmd
correl
increas
tumour
immun
reactiv
suggest
tumour
may
also
respond
better
immunotherapi
togeth
enhanc
immun
reactiv
tumour
mutat
nmd
pathway
suggest
inhibit
nmd
may
serv
effect
strategi
potenti
efficaci
checkpoint
inhibitor
prevent
destruct
ptccontain
transcript
reduc
nmd
activ
may
enhanc
express
tumour
antigen
recogn
immun
system
foreign
neoantigen
anoth
studi
identifi
potenti
benefit
within
subgroup
colorect
cancer
crc
character
high
level
mrna
ptc
consequ
microsatellit
instabl
msi
diseas
inhibit
nmd
vivo
use
amlexanox
reduc
cell
prolifer
antitumour
effect
msi
tumour
xenograft
interestingli
major
effect
seen
microsatellit
stabl
colorect
cancer
cell
line
central
toler
process
elimin
develop
b
lymphocyt
reactiv
self
propos
new
peptid
produc
result
aberr
splice
nmddepend
autoregul
altern
splice
elicit
tcell
respons
subject
host
central
toler
thymu
lack
express
healthi
tissu
therefor
transcript
nmd
inhibit
tumour
cell
abl
induc
immun
respons
inhibit
tumour
growth
furthermor
observ
frameshift
mutat
tumour
cell
exhibit
dna
mismatch
repair
produc
ptccontain
mrna
neg
control
nmd
therefor
nmd
inhibit
could
stimul
product
tumourspecif
antigen
search
nmd
inhibitor
yield
good
candid
vari
effect
small
molecul
term
nmdi
stabil
hyperphosphoryl
isoform
protein
reduc
interact
protein
moreov
compound
compromis
interact
also
identifi
combin
compound
ptc
readthrough
drug
enhanc
restor
fulllength
make
direct
interact
ejc
compon
pateamin
pata
natur
product
inhibit
nmd
curcumin
dietari
compound
inhibit
nmd
downregul
express
transcript
level
pyrimidin
deriv
also
identifi
inhibitor
protein
upon
block
nmd
inhibitor
wortmannin
caffein
found
increas
express
mutant
collagen
vi
subunit
cardiac
glycosid
eg
digoxin
ouabain
increas
cytoplasm
calcium
repress
nmd
pathway
moreov
screen
hela
cell
stabli
express
nmd
report
use
librari
clinic
licens
compound
identifi
analog
natur
occur
nucleosid
cytidin
previous
approv
treatment
myelodysplast
syndrom
myeloid
leukaemia
inhibitori
effect
compound
depend
induct
myc
express
shown
inhibit
nmd
xray
diffract
translat
necessari
nmd
thu
suggest
inhibitor
translat
may
also
effect
inhibitor
nmd
moreov
martin
et
al
recent
demonstr
nmd
inhibit
achiev
via
mechan
also
determin
deplet
suppress
nmd
activ
influenc
prolifer
surviv
cell
therefor
inhibitor
modul
nmd
activ
offer
critic
tool
understand
mechan
physiolog
function
nmd
pathway
target
proteinprotein
interact
bind
site
crucial
drug
discoveri
sinc
mani
physiolog
patholog
cellular
process
depend
proteinprotein
interact
influenc
compound
peptidelik
molecul
although
previou
studi
identifi
nmd
inhibitor
differ
mechan
action
eg
disrupt
interact
sever
interact
activesit
left
exploit
studi
threedimension
protein
structur
reveal
precis
interact
defin
proteinprotein
interfac
silico
drug
design
target
drug
discoveri
proteinprotein
structur
avail
protein
data
bank
http
wwwrcsborgpdb
nmd
pathway
figur
tabl
ejc
figur
illustr
differ
proteinprotein
proteinrna
interact
nmd
pathway
could
repres
base
platform
design
inhibitor
peptidelik
molecul
nonsensemedi
mrna
decay
critic
rna
qualiti
control
play
vital
role
recognit
ptc
transcript
well
regular
homeostasi
transcriptom
nmd
implic
develop
dna
damag
respons
cell
cycl
regul
immun
system
function
involv
maintain
genom
stabil
disrupt
strictli
regul
surveil
pathway
lead
patholog
includ
neurolog
disord
immun
diseas
cancer
role
nmd
cancer
develop
complex
case
nmd
act
support
tumour
growth
downregul
key
tumour
suppressor
gene
case
tumour
adjust
nmd
activ
adapt
microenviron
cancertarget
nmd
inhibit
might
repres
new
strategi
promot
protect
antitumour
immun
antigen
express
tumour
cell
may
less
immunogen
effort
avoid
immunesystem
instead
stimul
immun
respons
less
effect
antigen
goal
novel
tumour
vaccin
protocol
gener
new
antigen
determin
inhibit
nmd
order
design
effect
nmd
inhibitor
structur
aspect
pathway
must
studi
differ
proteinprotein
proteinrna
interact
understand
mechan
nonsensemedi
mrna
decay
might
lead
new
way
use
surveil
cancer
therapi
ptcassoci
genet
diseas
